- TWD24.42bn
- TWD20.51bn
- TWD1.76bn
- 90
- 13
- 96
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,543 | 2,398 | 2,750 | 2,102 | 1,761 |
Cost of Revenue | |||||
Gross Profit | 1,639 | 1,520 | 1,695 | 1,214 | 1,045 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,473 | 1,529 | 1,681 | 1,469 | 1,302 |
Operating Profit | 1,070 | 869 | 1,069 | 634 | 458 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,053 | 804 | 1,045 | 734 | 506 |
Provision for Income Taxes | |||||
Net Income After Taxes | 867 | 655 | 826 | 592 | 413 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 853 | 660 | 828 | 597 | 426 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 853 | 660 | 828 | 597 | 426 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 19.9 | 14.9 | 18.4 | 13.2 | 8.18 |
Dividends per Share |